Male carriers of HLA-C*04:01 have increased risk of cardiac injury in COVID-19
Phillip Suwalski , Michele Violano , Melina Müller , Dimitri Patriki , Charlotte Thibeault , Claudia Quedenau , Xiaomin Wang , Zehra Karadeniz , Jacopo Saccomanno , Jan-Moritz Doehn , Ralf-Harto Hübner , Bernd Hinzmann , H. Juerg Beer , Benedikt Wiggli , Sandra Siemann , Norbert Suttorp , Martin Witzenrath , Stefan Hippenstiel , Carsten Skurk , Wolfgang Poller , Pa-COVID Study Group , Leif E. Sander , Florian Kurth , Tatiana Borodina , Toumy Guettouche , Ulf Landmesser , Bettina Heidecker
The Journal of Cardiovascular Aging ›› 2022, Vol. 2 ›› Issue (3) : 33
Male carriers of HLA-C*04:01 have increased risk of cardiac injury in COVID-19
Identification of factors that lead to the severe clinical course of COVID-19 is crucial for timely allocation of resources. The purpose of this study was to evaluate possible sex differences in cardiac injury associated with HLA-C*04:01. High sensitivity troponin T on admission (hs-TnTa) and maximum high sensitivity troponin T (hs-TnTmax) were used to assess for cardiac injury in patients with COVID-19 (n = 435). We tested for the association of elevated hs-TnT with HLA-C* 04:01 and evaluated for potential sex-specific differences. An association between hs-TnTa and the severity of clinical course was identified. In addition, our study revealed that hs-TnTmax was higher in men who were carriers of HLA-C*04:01 compared to men without the risk allele. Male carriers of HLA-C*04:01 with COVID-19 developed higher hs-TnTmax, suggesting a larger extent of cardiac injury. This association suggests the presence of different pathomechanisms in COVID-19 based on sex.
Genetic, HLA, HLA-C / HLA-C*04:01, COVID-19, troponin T, hs-TnT
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
/
| 〈 |
|
〉 |